Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Bioregenx (BRGX) Equity Ratio (2021 - 2025)

Bioregenx's Equity Ratio history spans 5 years, with the latest figure at 11.04 for Q4 2025.

  • Quarterly results put Equity Ratio at 11.04 for Q4 2025, down 66.14% from a year ago — trailing twelve months through Dec 2025 was 11.04 (down 66.14% YoY), and the annual figure for FY2025 was 11.04, down 66.14%.
  • Equity Ratio for Q4 2025 was 11.04 at Bioregenx, down from 3.12 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.81 in Q1 2024 to a low of 82.34 in Q3 2023.
  • The 5-year median for Equity Ratio is 4.91 (2024), against an average of 15.59.
  • The sharpest move saw Equity Ratio crashed 6382.36% in 2022, then surged 102.63% in 2024.
  • Year by year, Equity Ratio stood at 0.66 in 2021, then plummeted by 6382.36% to 42.74 in 2022, then surged by 94.4% to 2.39 in 2023, then tumbled by 177.73% to 6.65 in 2024, then tumbled by 66.14% to 11.04 in 2025.
  • According to Business Quant data, Equity Ratio over the past three periods came in at 11.04, 3.12, and 3.18 for Q4 2025, Q3 2025, and Q2 2025 respectively.